beta
/Long-term Function and Survival of Radicava ORS® (Oral Edaravone)-Treated Patients With ALS vs Propensity Score–Matched PRO-ACT Historical Controls (P8-2.003)
Abstract

Abstract N/A

RelatedView All
Authors 10View All
CitationsView All
Citing-
Cited By-